MGMT and glioblastoma: We investigated responses to two human equivalent TMZ doses and could demonstrate that 164 mg/m2 that was closest to the 200 mg/m2 administered to recurrent patients was most effective as it (i) prolonged progression free survival and (ii) overall survival in animals bearing GBM with unmethylated MGMT promoter.